January 1, 2015

Radius: The Top Performing IPO of 2014

Radius, which is developing treatments for osteoporosis, is up 364% since pricing its June 6 initial public offering at 8

BY BRIAN DEAGON, INVESTOR’S BUSINESS DAILY
12/24/2014 03:53 PM ET

Read More At Investor’s Business Daily: http://news.investors.com/technology/122414-732039-radius-auspex-kite-lead-biotechs-as-best-ipos-of-2014.htm#ixzz3RO49lZt5
Follow us: @IBDinvestors on Twitter | InvestorsBusinessDaily on Facebook

As 2014 nears a close, the biotech industry holds four of the top five spots among the best-performing IPOs of the year, led by Radius Health (NASDAQ:RDUS).
Radius, which is developing treatments for osteoporosis, is up 364% since pricing its June 6 initial public offering at 8.

The No. 2 performer is Auspex Pharmaceuticals (NASDAQ:ASPX), which is developing treatments for central nervous disorders. The stock is up 316% from its Feb. 5 IPO price of 12.

One tech company, TubeMogul (NASDAQ:TUBE), made it into the top five. TubeMogul stock is up 237% from its July 18 IPO price of 7. TubeMogul provides automated online ad-buying services for brand advertisers.
No. 4 is Kite Pharma (NASDAQ:KITE), which is up 206% from its June 20 IPO price of 17. Kite is among a handful of companies developing breakthrough cancer-curing therapies in a field called cellular immunotherapy. It uses a white blood cell known as the T cell as therapeutics to recognize and kill cancer cells.